1. Home
  2. ATLO vs SKYE Comparison

ATLO vs SKYE Comparison

Compare ATLO & SKYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.57

Market Cap

239.2M

Sector

Finance

ML Signal

HOLD

Logo Skye Bioscience Inc.

SKYE

Skye Bioscience Inc.

HOLD

Current Price

$0.58

Market Cap

44.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
SKYE
Founded
1903
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.2M
44.9M
IPO Year
2001
2013

Fundamental Metrics

Financial Performance
Metric
ATLO
SKYE
Price
$27.57
$0.58
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$15.00
AVG Volume (30 Days)
36.4K
285.3K
Earning Date
04-16-2026
03-10-2026
Dividend Yield
2.90%
N/A
EPS Growth
8.03
N/A
EPS
0.38
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$72.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.09
$0.60
52 Week High
$28.35
$5.75

Technical Indicators

Market Signals
Indicator
ATLO
SKYE
Relative Strength Index (RSI) 60.11 32.30
Support Level $26.00 N/A
Resistance Level $28.28 $0.83
Average True Range (ATR) 0.65 0.05
MACD 0.05 -0.00
Stochastic Oscillator 86.81 1.06

Price Performance

Historical Comparison
ATLO
SKYE

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

About SKYE Skye Bioscience Inc.

Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.

Share on Social Networks: